United States · FDA National Drug Code directory
DOXEPIN HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2647_73479b35-852c-4091-82e1-7743c681582a
- Product NDC
- 71335-2647
- Form
- CAPSULE
- Composition / generic term
- DOXEPIN HYDROCHLORIDE
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210423
- Source listing expiry
- 20261231
Source-listed ingredients
- DOXEPIN HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (71335-2647-1) · 71335-2647-1
- 60 CAPSULE in 1 BOTTLE (71335-2647-2) · 71335-2647-2
- 18 CAPSULE in 1 BOTTLE (71335-2647-3) · 71335-2647-3
- 90 CAPSULE in 1 BOTTLE (71335-2647-4) · 71335-2647-4
- 180 CAPSULE in 1 BOTTLE (71335-2647-5) · 71335-2647-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →